Angiography Imaging Systems Market Analysis by Product Type (Angiography Contrast Media, and Others); by Technology (Computed Tomography, X-Ray Machines, MRI, and MRA); by Application (Neurology, Cardiology, Oncology, Vascular, and Peripheral Intervention); and by End-User (Hospitals, Laboratories, and Other) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035
Buy Now Report ID: 4138 | Published Date: Mar 01, 2023
The global angiography imaging system market is estimated to garner a revenue of ~USD 10 Billion by the end of 2035 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of ~USD 5 Billion in the year 2022. The growth of the market can be attributed to the rising requirement to diagnose blood vessel diseases and increasing cases of cardiovascular diseases among the population around the world. Data represented by the World Health Organization (WHO) showed, that in 2019, approximately 17.9 million people lost their lives due to cardiovascular diseases across the globe.
In addition to the above-mentioned factors, the escalation in tumor-related diseases among the global population is also one of the major factors for the high utilization rate of angiography systems in the healthcare sector. Angiography imaging systems use electromagnetic radiation diagnosis that is used to inspect blood vessels. Once the blood vessels are investigated, and a potential tumor or underlying disease is detected, the cardiologists then proceed with the process of angioplasty. Moreover, the shift towards unhealthy lifestyles with the addition of consumption of junk and reduced physical activity is encouraging the development of numerous health issues in the human body such as obesity and diabetes which subsequently generates the demand for angiography imaging systems for diagnosing central points of diseases. Other than that, the growing focus on adopting non-invasive procedures for diagnosing and treating the process of the majority of intravascular diseases is expected to create more potential for angiography imaging systems and expansion of the market size during the analysis period. Furthermore, the recent development of imaging technologies has propelled the introduction of advanced angiography systems, which is further projected to expand the market size. In addition, high investments made in the healthcare systems for delivering the best treatment along with enhancing the patient experience are also predicted to bring lucrative growth opportunities for market expansion.
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~7% |
|
Base Year Market Size (2022) |
~ USD 5 Billion |
|
Forecast Year Market Size (2035) |
~ USD 10 Billion |
|
Regional Scope |
|
Growth Drivers
Growing Cases of Cancers and Strokes – Rising adoption of unhealthy lifestyles is attributed to an increase in the cases of cancers and strokes among the global population. This trend is expected to surge the need for angiography imaging systems for timely diagnosis and improved treatment. The data released by the World Health Organization (WHO) stated that cancers took almost 9.3 million lives and diabetes killed approximately 2 million individuals across the globe.
Escalation in Expenditure for Integration of Advanced Medical Products – As a result of the rising number of diseases worldwide, the need for early diagnosis of disorders and improve detection of diseases is expected to promote the adoption of advanced imaging systems in the healthcare system. The rising healthcare expenditure of individuals and hospitals is therefore projected to create a positive opportunity for the adoption of angiography imaging systems, which in turn, is expected to drive the growth of global angiography imaging systems. According to the statistics by the Centers for Medicare & Medicaid Services (CMS) of the United States government, hospital expenditure in the United States was calculated to be USD 1270.1 Billion in 2020, with a significant growth of 6.4% in the same year, up from 6.3% in the year 2019.
High Prevalence of Chronic Diseases – Chronic diseases are difficult to handle and require specific medical equipment for treatment. Thus, as the cases of chronic diseases are increasing, the requirement for technologically advanced angiography imaging systems is also anticipated to grow subsequently. As per the data released by the Centers for Disease Control and Prevention (CDC), six out of ten Americans are diagnosed with at least one chronic disease such as heart disease and stroke, or diabetes.
Rapid Adoption of Automation in the Healthcare Industry – Recent statistics reveal that almost 5% of global healthcare shareholders were investing in robotic process automation (RPA) in 2020. This figure is forecasted to grow to over 50% in 2023.
Surge in Expenditure for Development of Advanced Medical Equipment – As the global healthcare industry is rising, the need for technologically advanced medical products is also increasing for providing better healthcare facilities to patients. As a result, major key players and the government are investing in research and development activities to introduce novel and advanced angiography imaging systems for a better process. According to the World Bank, global expenditure on research and development was calculated to be 2.63% of GDP in 2020 up from 2.2% in 2018.
Challenges
The global angiography imaging system market is segmented and analyzed for demand and supply by application into neurology, cardiology, oncology, vascular, and peripheral intervention. Out of these, the cardiology segment is attributed to garner the highest segment share of the market by the end of 2035. The major factor attributed to segment growth is the rising cases of heart diseases and increasing awareness about timely diagnosis and proper treatment. The data released by the Centers for Disease Control and Prevention (CDC) stated that heart diseases took almost 697,000 lives in the United States in 2020 which is equivalent to 1 in every 5 deaths. As a result of the high prevalence of heart diseases among the global population is estimated to help and expand the cardiology sector. In addition, the presence of a high number of cardiologists across every region of the world is another factor for the expansion of the cardiology segment in the near future.
The global angiography imaging system market is also segmented and analyzed for demand and supply by end-user in hospitals, laboratories, and others. Out of these three segments, the hospitals segment is attributed to garner the most significant segment share with a noteworthy CAGR over the forecast period. The presence of a large number of hospitals across the globe and the high count of patients visiting hospitals on an everyday basis is the major factor for the expansion of the segment during the assessment period. Furthermore, individuals who are diagnosed with both chronic and acute diseases, often visit hospitals which makes the utilization rate of angiography imaging systems much more convenient. Moreover, the high investments made by governments of different countries to enhance the hospital settings are another factor boosting a significant revenue generation of the segment in the upcoming years.
Our in-depth analysis of the global angiography imaging system market includes the following segments:
|
By Product Type |
|
|
By Technology |
|
|
By Application |
|
|
By End-User |
|
The North America angiography imaging system market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035 on the back of a growing number of testing libraries and a higher prevalence of cardiovascular diseases in the region. Centers for Disease Control and Prevention (CDC) published a report showing that heart diseases cost USD 229 billion each year from 2017 to 2018. Furthermore, escalating manufacturing of testing laboratories is anticipated to hike the growth of the market over the forecast period. In 2020, it was noticed that the federal government of the USA spent more than USD 1 billion on the construction and development of testing laboratories. Additionally, the growing geriatric population in the region with multiple diseases and disorders is also forecasted to boost the growth of the market. Data released by the World Bank stated that in 2020, the total geriatric population in the USA was 55,131,698. Also, the rapid technological advancement has facilitated the development of advanced angiography imaging systems such as robotic angiography systems in the region.
Furthermore, the global angiography imaging system market is also projected to grow at a significant pace in the Asia Pacific region during the forecast period. The growth of the market in the region is accounted to factors such as the higher prevalence of cardiovascular and cardio metabolism diseases and the rapidly growing geriatric population. Other factors that are projected to expand the global angiography imaging system market in the region are the rising disposable income, high healthcare expenditure, and the presence of a robust healthcare system. Also, the rising focus to develop advanced medical equipment is considered to extend profitable opportunities for market players of the market in the region and expand the growth rate in the future.
Siemens Healthineers, a German medical device company, declared in 2019 that its latest high-precision angiography device, ARTIS icono, had received FDA 510(k) approval.
NIDEK CO., LTD. has announced AngioScan, an upgraded OCT-Angiography software. It enables RS-3000 Advance 2 Optical Coherence Tomography consumers to witness the microvasculature and blood circulation in the ocular and choroidal cells.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Rising requirements to diagnose blood vessel diseases and growing cases of cardiovascular diseases are the major factors driving the growth of the angiography imaging system market.
Ans: The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 – 2035.
Ans: A need for higher initial investment coupled with increased costs of systems along with unfavorable reimbursement policies are other factors that are estimated to hamper the market growth.
Ans: The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are Omega Medical Imaging, LLC., Canon Inc., Siemens Aktiengesellschaft, Koninklijke Philips N.V., Shimadzu Corporation, Eagle Biosciences, Inc., Merck KGaA, ERBA Diagnostics, Inc., Zeus Scientific Inc., Trinity Biotech plc., and other key players.
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by product type, technology, application, end-user, and by region.
Ans: The MRA segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities
Submit Your Request For Proposal (RFP)
